BIOLASE (NASDAQ: BIOL) Stock Jumps on EPS Beat, but Revenue Misses Mark
BIOLASE (NASDAQ: BIOL) stock soared 20% on Friday after the company beat EPS forecasts in the fourth quarter. However, the […]
BIOLASE (NASDAQ: BIOL) Stock Jumps on EPS Beat, but Revenue Misses Mark Read More »
